Keybanc Initiates Coverage On Evolent Health with Overweight Rating, Announces Price Target of $35
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Matthew Gillmor has initiated coverage on Evolent Health with an Overweight rating and set a price target of $35.
October 11, 2024 | 3:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Keybanc has initiated coverage on Evolent Health with an Overweight rating and a price target of $35, indicating a positive outlook.
The initiation of coverage with an Overweight rating and a specific price target of $35 by Keybanc suggests a positive sentiment towards Evolent Health. This could lead to increased investor interest and potentially a rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100